UPDATE: Merck KGaA, Pfizer (PFE) to Terminate JAVELIN Ovarian 100 Trial of Avelumab

December 21, 2018 2:03 PM
(Updated - December 21, 2018 2:06 PM EST)

Merck KGaA, Darmstadt, Germany, and Pfizer Inc. (NYSE: PFE) today announced ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot FDA News

Next Articles